8 March 2017 – Statement of the European Union – HRC 34 – Panel on Access to Medicines

Posted on by Thiru

On 8 March 2017, the European Union (EU) delivered the following statement to the Human Rights Council’s panel discussion on Access to Medicines. As the Human Right Council imposed a strict two minute limit on interventions, the EU was not able to raise the following two questions contained at the end of its intervention.

I have two questions for the Panel.

Could the panellists suggest further measures to promote a holistic approach to access to medicines?

Continue Reading →

8 March 2017 – Statement of the World Trade Organization – HRC 34 – Panel on Access to Medicines

Posted on by Thiru

On 8 March 2017, the World Trade Organization delivered the following statement at the Human Rights Council’s panel on Access to Medicines.

WTO statement – Antony Taubman

It’s an honour for the WTO Secretariat to join this distinguished panel. Today’s discussion is a welcome step forward in the journey together towards the shared goal of access to medicines for all, and promoting the development of urgently needed new medicines, recognizing the centrality of the human rights perspective for this collective effort.

Continue Reading →

Uncategorized

Notes on 2017 Special 301 Submissions

Posted on by Zack Struver

Wednesday, March 8, 2017, the Office of the United States Trade Representative (USTR) will hold the first Special 301 Hearing of the Trump administration. This year, USTR received 63 submissions in advance fo the hearing from governments, civil society organizations, and industry groups.

This blog post pulls out interesting selections from the various submissions, and includes as attachments the submissions of selected organizations.
Continue Reading →

8 March 2017 – Human Rights Council’s Access to Medicines panel set to discuss Report of UN HLP

Posted on by Thiru

On 8 March 2017, the Human Rights Council will convene a three hour Access to Medicines panel which will take place from 3 PM to 6 PM in Room XX of the Palais des Nations in Geneva. This panel is mandated by resolution 32/15 which passed at 32nd session of the Human Rights Council (June/July 2016). The resolution directed the Human Rights Council to convene an access to medicines panel at its 34th session in March 2017.

Continue Reading →

1 March 2017 – WTO TRIPS Council – India’s statement on Non-Violation and Situation Complaints

Posted on by Thiru

On 1 March 2017, India delivered the following intervention on Non-Violation and Situation Complaints at the WTO TRIPS Council.

Agenda Item 8. Non-Violation and Situation Complaints

Mr.Chairman, my delegation would like to thank the delegation of Kyrgyz Republic for joining as co-sponsor of document W385 Rev.1.

Continue Reading →

1 March 2017 – WTO TRIPS Council – India’s intervention on the Report of the UN High-Level Panel on Access to Medicines

Posted on by Thiru

On 1 March 2017, India delivered the following statement during WTO TRIPS Council discussions on the United Nations Secretary-General’s High Level Panel Report on Access to Medicines.

Agenda item 12: the United Nations Secretary-General’s High Level Panel Report on Access to Medicines

Thank you Chairman.

At the outset, I would like to thank delegations of Brazil, China and South Africa who are also co-sponsors of this agenda item.

Continue Reading →

1 March 2017 – WTO TRIPS Council – Brazil’s intervention on the Report of the UN High-Level Panel on Access to Medicines

Posted on by Thiru

On 1 March 2017, Brazil delivered the following statement during WTO TRIPS Council discussions on the Report of the United Nations High-Level Panel on Access to Medicines.

High Level Panel

As we all know, on 19 November 2015, United Nations Secretary General Ban Ki-moon announced the creation of the High-Level Panel on Innovation and Access to Health Technologies. Responding to this invitation, two chairs were designated to the panel, namely, Ms. Ruth Dreifuss, from Switzerland, and Festus Mogae, from Botswana.

Continue Reading →